Tag: Intermittent
Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Leafcann edible important oils vary hits the market
© iStock / Stefan Tomic
Plant-Based Medical Industry Pioneers...
Workshop to debate multispecialty ideas on managing diabetes with CV, renal illness
Source / information
Published by:
Source:
Healio interview
Disclosure:
Healio is media partner for Evolving Concepts in the Management...